September 14, 2011 3:29:19 am
Eli Lilly and Company,a global pharmaceutical company,on Tuesday announced a $30 million commitment for over five years to fight the non-communicable diseases (NCD) in developing nations. Lilly is launching The Lilly-NCD Partnership,which combines the companys unique resources with the expertise of leading global health organisations,aims at identifying new models of patient care that increase treatment access for people. The partnership will focus on diabetes and cancer – two core business areas in which Lilly has deep expertise.
Non-communicable diseases,known as chronic diseases,include cardiovascular diseases,diabetes,cancer and chronic respiratory diseases. The first phase of The Lilly-NCD Partnership will focus on improving diabetes care in targeted communities in Brazil,India,Mexico and South Africa.
Non-communicable diseases are ravaging nations,communities and families around the world,with the most vulnerable bearing most of the burden, said John C Lechleiter,Lilly chairman,president,and chief executive officer. We believe we are uniquely positioned and have a responsibility to assist in the global fight against chronic diseases. Chronic diseases disproportionately affect the economically disadvantaged,with 80 per cent of all NCD deaths occurring in low- and middle-income countries.
NCDs claimed the lives of 36 million people in 2008,according to World Health Organization,representing 63 per cent of all global deaths. NCDs are a major contributor to poverty and a barrier to social and economic development.
Best of Express Premium
📣 Join our Telegram channel (The Indian Express) for the latest news and updates
- The Indian Express website has been rated GREEN for its credibility and trustworthiness by Newsguard, a global service that rates news sources for their journalistic standards.